# AMRTE — PROMPT 24 DELIVERY REPORT

## Version

0.24.0

## Baseline

0.23.1 — Prompt 23 accepted; 693 tests passed.

## Prompt 24 Status

ACCEPTED

## Strategy Health

HEALTHY: implemented; multiplier preserves upstream exposure only.  
CAUTION: implemented; configurable reduction.  
DEFENSIVE: implemented; stronger configurable reduction.  
SUSPENDED: implemented; zero positive future allocation.  
Insufficient history: explicit probation state and multiplier.  
Stale: explicit and fail-closed.  
Invalid: explicit and fail-closed.  
Unknown: explicit and fail-closed.

## Expected Behavior

Profile architecture: immutable `StrategyExpectedBehaviorProfile`.  
Versioning: profile ID/version and strategy version retained.  
Provenance: required explicit source string.  
Anti-look-ahead: profile `KnownAtUTC` and `ValidFromUTC` must be no later than evaluation.

## Performance Metrics

Completed count, cumulative/mean/median normalized R, win/loss/neutral rates,
positive/negative averages, expectancy, rolling peak, maximum drawdown,
consecutive negative outcomes, dispersion, downside deviation, and average
holding duration.

## Rolling Windows

Multiple configurable completed-observation windows with independent minimum
sample rules and immutable evidence. Regime-conditioned metrics require their
own minimum sample.

## Health Transitions

Deterioration: configurable fast confirmation with hard restrictive states.  
Recovery: requires new authoritative outcomes.  
Hysteresis: restrictive published state retained during recovery confirmation.  
Confirmation: separate deterioration and recovery counts.  
Cooldown: configurable recovery time.  
Probation: conservative multiplier for insufficient history.

## Dynamic Allocation

Healthy multiplier: 1.00 default  
Caution multiplier: 0.75 default  
Defensive multiplier: 0.35 default  
Suspended multiplier: 0  
Maximum permitted multiplier: 1.00  
`Multiplier <= 1`: CONFIRMED

## Profit-Chasing Protection

`RecentProfitCanIncreaseRisk = FALSE`

Positive performance can support health recovery but cannot exceed Prompt 23
approval or restore any Prompt 22/23 reduction.

## Strategy / Variant / Family

Strategy ID, strategy version, variant and family are isolated in observation
selection and snapshot identity. Optional family health composes through the
most restrictive multiplier; no unused capacity is reallocated.

## Regime Health

Implemented through admission-regime cohorts with independent minimum-sample
requirements. Sparse cohorts remain unavailable rather than appearing healthy.

## Recovery

Outcomes, transitions, published health and confirmation/cooldown metadata are
persisted. Schema, engine and configuration mismatches fail closed. Derived
statistics and snapshots rebuild deterministically.

## Temporal Integrity

PASS: outcome availability, future-profile rejection, strategy-version
isolation, immutable snapshots, duplicate prevention and historical replay.

## Metamorphic Tests

PASS for ordering/deduplication, allocation monotonicity, family restriction,
upstream reductions, outcome-set identity and profit-streak non-amplification.

## Failure Injection

PASS for non-finite outcomes, future profiles, invalid multipliers/windows,
transition configuration, stale evidence and incompatible recovery.

## Prompt 22 Integration

PASS — Prompt 22 remains portfolio capacity/accounting authority.

## Prompt 23 Integration

PASS — `Prompt24ApprovedExposure <= Prompt23ApprovedExposure`; Prompt 24 creates
no capacity reservation and cannot restore a Prompt 23 reduction.

## Phase V Master Gate

- Portfolio risk and reservation authority: PASS
- Correlation/concentration authority: PASS
- Strategy health authority: PASS
- No authority collision: PASS
- Monotonicity and no amplification: PASS
- Temporal integrity and restart: PASS
- `NO_ACTION`: PASS
- Research-only safety: PASS

## Testing

Prompt 24 focused: 19 passed  
Prompt 1–23 regression: 693 passed  
Total: 712 passed  
Failed: 0  
Skipped: 0

## Compilation

PASS — module compilation, full collection, and full test suite.

## Performance

Focused suite duration: 0.518 seconds  
Peak memory: 34,588 KiB  
Scope: bounded test-scale measurement; no production-scale claim.

## Windows

Static: PASS — OS-neutral Python, no shell/GUI/path dependency.  
Native: NOT PERFORMED.

## Safety

PASS — offline fictional research only. No broker connectivity/authentication,
account access, live feed, margin, leverage, real monetary P&L, orders,
position management, or real/demo execution.

## Gap Scan

Implemented: all acceptance-critical Prompt 24 requirements, including outcome
integrity, rolling metrics, expected profiles, health states, transition safety,
bounded multipliers, recovery, traceability, and Phase V integration.  
Partially implemented: advanced distribution/change-point diagnostics use
transparent deterministic metrics rather than a dedicated change-point model.  
Deferred by design: optional relative-strategy comparison and richer validation
baselines owned by Prompts 31 and 33–35.  
Deferred by safety scope: all broker/account/live/execution capabilities.  
Technical debt: native Windows runtime execution remains pending.  
Not implemented: none that block Prompt 24 or Phase V.  
Blocked: none.

## Known Limitations

Observation-count windows are implemented; elapsed-time windows are not enabled.
Advanced statistical calibration awaits the later research-validation phases.
Native Windows execution was not performed.

## Package

Archive: `AMRTE_Prompt_24_v0.24.0.zip`  
SHA-256: recorded in `AMRTE_Prompt_24_v0.24.0.sha256`

## Phase V Acceptance

ACCEPTED

## Ready for Prompt 25

YES
